Clinical Trials Directory

Trials / Completed

CompletedNCT04639765

Responses to Information on Treatments for Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Ohio State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the impact of different messages about depression treatments.

Detailed description

Participants recruited through Amazon Mechanical Turk (MTurk) will complete a screening questionnaire and provided the opportunity to consent to participate. Upon entry to the study, eligible participants will complete several questionnaires pre- and post-randomization. Randomization will be to view either a video detailing a type of depression treatment (cognitive behavioral therapy, antidepressant medication, or the combination of both treatments) with and without an emphasis on personalization. A no video condition is also included.

Conditions

Interventions

TypeNameDescription
OTHERCBT without PersonalizationIntervention involves a video describing CBT without a message about personalization.
OTHERCBT with PersonalizationIntervention involves a video describing CBT with a message about personalization.
OTHERADM without PersonalizationIntervention involves a video describing antidepressant medication without a message about personalization.
OTHERADM with PersonalizationIntervention involves a video describing antidepressant medication with a message about personalization.
OTHERCombined Treatment without PersonalizationIntervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization.
OTHERCombined Treatment with PersonalizationIntervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization.

Timeline

Start date
2020-10-28
Primary completion
2020-12-30
Completion
2020-12-30
First posted
2020-11-20
Last updated
2021-09-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04639765. Inclusion in this directory is not an endorsement.